Family · Pharmaceutical analytical standards
Oxcarbazepine
An antiepileptic derived from carbamazepine, approved in Denmark in 1990 and in the United States in 2000; it is used to treat focal seizures in epilepsy. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?It is a prodrug: in the body it is converted into its 10-hydroxy metabolite (MHD, also called licarbazepine), which is the real active form.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
